Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bioshares Biotech Products (BBP)

Bioshares Biotech Products (BBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BioShares
  • Assets Under Management 27,825,000
  • Market Capitalization, $K 27,825
  • Shares Outstanding, K 700
  • 60-Month Beta 1.55
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.07 (0.18%)
  • Most Recent Dividend 0.072 on 12/20/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.73 +10.17%
on 10/16/19
40.10 -1.84%
on 11/13/19
+3.84 (+10.81%)
since 10/14/19
3-Month
34.56 +13.90%
on 10/02/19
40.10 -1.84%
on 11/13/19
+1.77 (+4.71%)
since 08/14/19
52-Week
31.02 +26.90%
on 12/24/18
46.39 -15.15%
on 04/08/19
+4.10 (+11.64%)
since 11/14/18

Most Recent Stories

More News
Top and Flop ETFs So Far in Q2

The top ETF stories so far this second quarter linger around upbeat U.S. economic data points and the U.S.-China trade talks.

SOXX : 234.74 (-0.33%)
KBWR : 52.09 (-0.01%)
XSD : 99.40 (-0.53%)
KBWP : 70.85 (-0.11%)
IAT : 49.15 (-0.10%)
BBP : 39.36 (-0.86%)
PBE : 51.53 (-0.38%)
CHIR : 17.44 (+0.03%)
XINA : 19.91 (+0.28%)
BCNA : 20.83 (+0.14%)
Top and Flop ETFs So Far in Q2

The top ETF stories so far this second quarter linger around upbeat U.S. economic data points and the U.S.-China trade talks.

SOXX : 234.74 (-0.33%)
KBWR : 52.09 (-0.01%)
XSD : 99.40 (-0.53%)
KBWP : 70.85 (-0.11%)
IAT : 49.15 (-0.10%)
BBP : 39.36 (-0.86%)
PBE : 51.53 (-0.38%)
CHIR : 17.44 (+0.03%)
XINA : 19.91 (+0.28%)
BCNA : 20.83 (+0.14%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

NVS : 89.51 (-0.39%)
LLY : 111.39 (-1.24%)
RHHBY : 37.3400 (-0.69%)
PFE : 36.55 (-0.14%)
JNJ : 130.96 (-0.24%)
SBIO : 35.65 (-0.42%)
BTEC : 33.70 (-0.47%)
BBP : 39.36 (-0.86%)
XBI : 83.67 (-0.68%)
ONCE : 110.81 (-0.50%)
ILMN : 298.44 (+0.07%)
ARKG : 31.10 (-0.89%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

NVS : 89.51 (-0.39%)
LLY : 111.39 (-1.24%)
RHHBY : 37.3400 (-0.69%)
PFE : 36.55 (-0.14%)
JNJ : 130.96 (-0.24%)
SBIO : 35.65 (-0.42%)
BTEC : 33.70 (-0.47%)
BBP : 39.36 (-0.86%)
XBI : 83.67 (-0.68%)
ONCE : 110.81 (-0.50%)
ILMN : 298.44 (+0.07%)
ARKG : 31.10 (-0.89%)
A Spread of Top-Ranked ETFs That Crushed the Market in Q1

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.

PTF : 74.25 (+0.31%)
BBP : 39.36 (-0.86%)
XBI : 83.67 (-0.68%)
BTEC : 33.70 (-0.47%)
XSW : 98.23 (+0.30%)
PGJ : 38.86 (-1.81%)
ASHR : 28.35 (+0.85%)
PXMG : 59.49 (-1.10%)
ASHX : 20.14 (+0.35%)
KBA : 31.29 (+0.29%)
A Spread of Top-Ranked ETFs That Crushed the Market in Q1

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.

PTF : 74.25 (+0.31%)
BBP : 39.36 (-0.86%)
XBI : 83.67 (-0.68%)
BTEC : 33.70 (-0.47%)
XSW : 98.23 (+0.30%)
PGJ : 38.86 (-1.81%)
ASHR : 28.35 (+0.85%)
PXMG : 59.49 (-1.10%)
ASHX : 20.14 (+0.35%)
KBA : 31.29 (+0.29%)
5 ETFs Shining With Green Returns & More Room to Run

These ETFs are in the green this year and are up for more gains.

DIA : 278.23 (+0.06%)
BBP : 39.36 (-0.86%)
ACWI : 76.88 (+0.01%)
IPO : 29.87 (+0.30%)
SPY : 309.55 (+0.15%)
QQQ : 201.43 (-0.08%)
MJ : 17.19 (-4.55%)
ONLN : 34.32 (+0.30%)
ASHX : 20.14 (+0.35%)
5 ETFs Shining With Green Returns & More Room to Run

These ETFs are in the green this year and are up for more gains.

DIA : 278.23 (+0.06%)
BBP : 39.36 (-0.86%)
ACWI : 76.88 (+0.01%)
IPO : 29.87 (+0.30%)
SPY : 309.55 (+0.15%)
QQQ : 201.43 (-0.08%)
MJ : 17.19 (-4.55%)
ONLN : 34.32 (+0.30%)
ASHX : 20.14 (+0.35%)
Top ETF Stories of February

Inside the top ETF events of the month of February.

RHHBY : 37.3400 (-0.69%)
CNXT : 28.32 (+0.99%)
DIA : 278.23 (+0.06%)
VWO : 42.00 (-0.05%)
ITOT : 69.97 (+0.13%)
EUFN : 18.57 (-0.05%)
DFE : 59.82 (-0.03%)
FXB : 124.90 (+0.23%)
SBIO : 35.65 (-0.42%)
BTEC : 33.70 (-0.47%)
FEP : 36.02 (-0.07%)
IPO : 29.87 (+0.30%)
BBP : 39.36 (-0.86%)
PEK : 40.45 (+0.85%)
Q : 103.48 (+0.55%)
Top ETF Stories of February

Inside the top ETF events of the month of February.

RHHBY : 37.3400 (-0.69%)
CNXT : 28.32 (+0.99%)
DIA : 278.23 (+0.06%)
VWO : 42.00 (-0.05%)
ITOT : 69.97 (+0.13%)
EUFN : 18.57 (-0.05%)
DFE : 59.82 (-0.03%)
FXB : 124.90 (+0.23%)
SBIO : 35.65 (-0.42%)
BTEC : 33.70 (-0.47%)
FEP : 36.02 (-0.07%)
IPO : 29.87 (+0.30%)
BBP : 39.36 (-0.86%)
PEK : 40.45 (+0.85%)
Q : 103.48 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BBP with:

Fund Summary

The BioShares Biotechnology Products Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 39.61
1st Resistance Point 39.49
Last Price 39.36
1st Support Level 39.22
2nd Support Level 39.07

See More

52-Week High 46.39
Fibonacci 61.8% 40.52
Last Price 39.36
Fibonacci 50% 38.71
Fibonacci 38.2% 36.89
52-Week Low 31.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar